<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03536065</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00162359</org_study_id>
    <nct_id>NCT03536065</nct_id>
  </id_info>
  <brief_title>Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery</brief_title>
  <acronym>ORIOLES</acronym>
  <official_title>Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES): A Quality Improvement Study of Prescribing Habits and Patient Education</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      ORIOLES is a non-randomized, pre-post intervention study designed to improve quality of&#xD;
      opioid prescribing and use after discharge for patients undergoing urologic surgery. The&#xD;
      study will initially focus on a pre-defined cohort of patients undergoing radical&#xD;
      prostatectomy. After the predefined study period for the pre-intervention arm, a three-part&#xD;
      intervention is employed to assess the effect on opioid prescribing and use in the&#xD;
      post-intervention arm. Pending results, the intervention may be applied to all surgeries in&#xD;
      the department for routine clinical care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the study is to reduce the amount of opioid analgesia prescribed after urologic&#xD;
      surgery in the Department of Urology at Johns Hopkins. The initiative focuses on patients&#xD;
      undergoing surgery for prostate cancer with radical prostatectomy including patients enrolled&#xD;
      in IRB00123618/NCT03006562. The pre-intervention arm will consist of patients enrolled August&#xD;
      2017 to January 2018. The intervention arm will consist of patient enrolled January 2018 to&#xD;
      completion of the study.&#xD;
&#xD;
      The intervention consists of a information discharge sheet, a standardized prescribing&#xD;
      guideline at discharge, and nurses providing improved education for patients at discharge&#xD;
      about appropriate use of opioid medication, routes for disposal, and potential side effects.&#xD;
      Data on prescriptions written (amount and type of mediation) and use of opioid and other pain&#xD;
      medication after surgery will be compared before and after the quality improvement initiative&#xD;
      is started. Outcomes are assessed via 30-day phone call follow-up with data on perioperative&#xD;
      outcomes, postoperative medication use, and symptoms already assessed in&#xD;
      IRB00123618/NCT03006562. At the completion of the pre-intervention arm, providers in the&#xD;
      urology department are informed about the average and distribution of usage of post-discharge&#xD;
      opioids. Education and standardized prescribing (allowing for provider judgment) may help&#xD;
      reduce/personalize the amount of opioids prescribed at discharge to reduce wasted medication&#xD;
      entering circulation. The initiative may then be expanded to encompass all surgeries in the&#xD;
      department to reduce opioid prescribing and use for routine clinical care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Pre-Post Study Design with Non-Pharmacologic Intervention</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Use</measure>
    <time_frame>30 days</time_frame>
    <description>The total oral morphine equivalents (OMEQ) used by the patient up to 30 days after discharge from the hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Prescription</measure>
    <time_frame>Discharge date</time_frame>
    <description>The total oral morphine equivalents (OMEQ) prescribed by the inpatient provider to the patient at discharge after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Disposal</measure>
    <time_frame>30 days</time_frame>
    <description>Method of disposal (if any) by the patient of opioid medication prescribed for post-discharge use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for Refill or Additional Opioid Medication</measure>
    <time_frame>30 days</time_frame>
    <description>Patient obtaining any additional opioid medication for post-surgical pain within 30 days after discharge from the hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">443</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Opioid Use</condition>
  <arm_group>
    <arm_group_label>Pre-Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Current practice (unchanged)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reduction of opioid prescription based on Pre-Intervention data, implementation of a discharge sheet and nursing education.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Opioid Reduction Intervention</intervention_name>
    <description>Patient education discharge sheet, nursing education, opioid prescription reduction based on Pre-Intervention data</description>
    <arm_group_label>Post-Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Current Care</intervention_name>
    <description>Current unchanged care provided; unchanged provider prescribing and unchanged education of patients prior to intervention</description>
    <arm_group_label>Pre-Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients diagnosed with prostate cancer and enrolled in NCT03006562&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients not undergoing radical prostatectomy (for the primary pre-post ORIOLES study)&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amin S Herati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Huang MM, Su ZT, Becker REN, Pavlovich CP, Partin AW, Allaf ME, Patel HD. Complications after open and robot-assisted radical prostatectomy and association with postoperative opioid use: an analysis of data from the PREVENTER trial. BJU Int. 2021 Feb;127(2):190-197. doi: 10.1111/bju.15172. Epub 2020 Aug 17.</citation>
    <PMID>32654363</PMID>
  </reference>
  <results_reference>
    <citation>Patel HD, Srivastava A, Patel ND, Faisal FA, Ludwig W, Joice GA, Schwen ZR, Allaf ME, Han M, Herati AS. A Prospective Cohort Study of Postdischarge Opioid Practices After Radical Prostatectomy: The ORIOLES Initiative. Eur Urol. 2019 Feb;75(2):215-218. doi: 10.1016/j.eururo.2018.10.013. Epub 2018 Oct 21.</citation>
    <PMID>30352714</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel HD, Faisal FA, Patel ND, Pavlovich CP, Allaf ME, Han M, Herati AS. Effect of a prospective opioid reduction intervention on opioid prescribing and use after radical prostatectomy: results of the Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES) Initiative. BJU Int. 2020 Mar;125(3):426-432. doi: 10.1111/bju.14932. Epub 2019 Nov 15.</citation>
    <PMID>31643128</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 14, 2018</study_first_submitted>
  <study_first_submitted_qc>May 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2018</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

